Most people have never heard of Cartalax. I think it's the peptide that gets healing done when BPC-157 and TB-500 stall out.This is the full masterclass. Cartalax is a three amino acid bioregulator from the Khavinson group in Russia. BPC and TB-500 work on growth factors at the cell surface. Cartalax goes inside the nucleus and changes which genes cartilage cells express. In cell culture it roughly doubled chondrocyte growth and raised SIRT1 and SIRT6, two longevity proteins that drop in arthritic joints. Human data is thin, so I'm clear about where the research ends and my experience begins.I cover why cartilage is so hard to heal, how Cartalax fits next to BPC, TB-500, GHK and KPV, my three dosing tiers from maintenance up to 2mg a day, dosing by goal, cycling logic, reconstitution, where to inject, and the full healing stack people are now calling Wolverine Plus. Plus troubleshooting, contraindications, and the FAQ on capsules, drug testing, bone on bone, and spine issues.There's also the story of how I found it, injecting one sore wrist and comparing it to the other.If you've stalled on the standard healing peptides, this one is for you.For research and entertainment purposes only. Subscribe for more peptide research and analysis.👇 ALL MY LINKS IN ONE PLACEhttps://hunterwilliamshealth.com/links

LL-37 is the peptide I think everyone should have on hand and almost nobody should be taking every day.

It's the only cathelicidin in the human body. That's an antimicrobial peptide your immune system makes to punch holes in bacteria, break up biofilms, and neutralize endotoxins. In this masterclass I walk through how it works. I cover why your vitamin D level decides whether your body can even make it. Then the specific situations where I reach for it. Stubborn sinus infections, bacterial acne, gut biofilms, suspected mold, and high-exposure travel windows.

I also cover who needs to stay away from it. Active autoimmune flares, rosacea, certain cancers, and mast cell issues can all go the wrong direction with LL-37.

Then dosing. I break down why I use 100 to 150mcg instead of the 2mg some people push. I go over how long a cycle should run and why maintenance dosing makes no sense. And I show how I sequence it with Thymosin Alpha 1, BPC-157, and TB-500.

One honest note. Almost all of the LL-37 data is preclinical or anecdotal. The only human trial is topical, and the lower doses beat the higher ones.

If you've ever wondered whether LL-37 belongs in your protocol, this one answers it.

For research and entertainment purposes only. Subscribe for more peptide research and analysis.

👇 ALL MY LINKS IN ONE PLACE
https://hunterwilliamshealth.com/links

All links here: https://hunterwilliamshealth.com/links